Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes

Patrícia Napoleão; Luís B P Cabral; Mafalda Selas; Cláudia Freixo; Maria do Céu Monteiro; Maria Begoña Criado; Marina C. Costa; Francisco J. Enguita; Ana Maria Viegas-Crespo; Carlota Saldanha; Miguel Mota Carmo; Rui Cruz Ferreira; Teresa Pinheiro

doi:10.1016/j.trsl.2016.04.005

Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes

Patrícia Napoleão, Luís B P Cabral, Mafalda Selas, Cláudia Freixo, Maria do Céu Monteiro, Maria Begoña Criado, Marina C. Costa, Francisco J. Enguita, Ana Maria Viegas-Crespo, Carlota Saldanha, Miguel Mota Carmo, Rui Cruz Ferreira, Teresa Pinheiro

Research output: Contribution to journal › Article

5 Citations (Scopus)

Abstract

Involvement of soluble CD40 ligand (sCD40L) in thrombosis and inflammation on the context of coronary artery disease is currently being revised. In that perspective, we had studied the association of sCD40L with markers of platelet activation and markers of endothelial and vascular function. On that cohort, a stratification of patients with acute myocardial infarction (AMI) 1 month after percutaneous coronary intervention (PCI) was observed based on concentrations of sCD40L. The study intended to identify the groups of AMI patients with different profiles of sCD40L concentrations and verify how medication, clinical evolution, biochemical data, and markers of regulation of endothelial function at genetic (endothelial nitric oxide synthase polymorphisms) and post-transcriptional levels (circulating microRNAs) affect sCD40L serum levels. Lower quartiles of sCD40L (

Original language	English
Pages (from-to)	95
Number of pages	104
Journal	Translational Research
DOIs	https://doi.org/10.1016/j.trsl.2016.04.005
Publication status	Published - Oct 2016

Access to Document

10.1016/j.trsl.2016.04.005

Link to publication in Scopus

Fingerprint Dive into the research topics of 'Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes'. Together they form a unique fingerprint.

Cite this

Napoleão, P., Cabral, L. B. P., Selas, M., Freixo, C., Monteiro, M. D. C., Criado, M. B., Costa, M. C., Enguita, F. J., Viegas-Crespo, A. M., Saldanha, C., Carmo, M. M., Ferreira, R. C., & Pinheiro, T. (2016). Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes. Translational Research, 95. https://doi.org/10.1016/j.trsl.2016.04.005

Napoleão, Patrícia ; Cabral, Luís B P ; Selas, Mafalda ; Freixo, Cláudia ; Monteiro, Maria do Céu ; Criado, Maria Begoña ; Costa, Marina C. ; Enguita, Francisco J. ; Viegas-Crespo, Ana Maria ; Saldanha, Carlota ; Carmo, Miguel Mota ; Ferreira, Rui Cruz ; Pinheiro, Teresa. / Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes. In: Translational Research. 2016 ; pp. 95.

@article{9e590f25e62842cc9c6174a8758d90f3,

title = "Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes",

abstract = "Involvement of soluble CD40 ligand (sCD40L) in thrombosis and inflammation on the context of coronary artery disease is currently being revised. In that perspective, we had studied the association of sCD40L with markers of platelet activation and markers of endothelial and vascular function. On that cohort, a stratification of patients with acute myocardial infarction (AMI) 1 month after percutaneous coronary intervention (PCI) was observed based on concentrations of sCD40L. The study intended to identify the groups of AMI patients with different profiles of sCD40L concentrations and verify how medication, clinical evolution, biochemical data, and markers of regulation of endothelial function at genetic (endothelial nitric oxide synthase polymorphisms) and post-transcriptional levels (circulating microRNAs) affect sCD40L serum levels. Lower quartiles of sCD40L (",

author = "Patr{\'i}cia Napole{\~a}o and Cabral, {Lu{\'i}s B P} and Mafalda Selas and Cl{\'a}udia Freixo and Monteiro, {Maria do C{\'e}u} and Criado, {Maria Bego{\~n}a} and Costa, {Marina C.} and Enguita, {Francisco J.} and Viegas-Crespo, {Ana Maria} and Carlota Saldanha and Carmo, {Miguel Mota} and Ferreira, {Rui Cruz} and Teresa Pinheiro",

note = "PMID: 27172386",

year = "2016",

month = oct,

doi = "10.1016/j.trsl.2016.04.005",

language = "English",

pages = "95",

journal = "Translational Research",

issn = "1931-5244",

publisher = "Elsevier Science B.V., Amsterdam.",

}

Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes. / Napoleão, Patrícia; Cabral, Luís B P; Selas, Mafalda; Freixo, Cláudia; Monteiro, Maria do Céu; Criado, Maria Begoña; Costa, Marina C.; Enguita, Francisco J.; Viegas-Crespo, Ana Maria; Saldanha, Carlota; Carmo, Miguel Mota; Ferreira, Rui Cruz; Pinheiro, Teresa.

In: Translational Research, 10.2016, p. 95.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes

AU - Napoleão, Patrícia

AU - Cabral, Luís B P

AU - Selas, Mafalda

AU - Freixo, Cláudia

AU - Monteiro, Maria do Céu

AU - Criado, Maria Begoña

AU - Costa, Marina C.

AU - Enguita, Francisco J.

AU - Viegas-Crespo, Ana Maria

AU - Saldanha, Carlota

AU - Carmo, Miguel Mota

AU - Ferreira, Rui Cruz

AU - Pinheiro, Teresa

N1 - PMID: 27172386

PY - 2016/10

Y1 - 2016/10

N2 - Involvement of soluble CD40 ligand (sCD40L) in thrombosis and inflammation on the context of coronary artery disease is currently being revised. In that perspective, we had studied the association of sCD40L with markers of platelet activation and markers of endothelial and vascular function. On that cohort, a stratification of patients with acute myocardial infarction (AMI) 1 month after percutaneous coronary intervention (PCI) was observed based on concentrations of sCD40L. The study intended to identify the groups of AMI patients with different profiles of sCD40L concentrations and verify how medication, clinical evolution, biochemical data, and markers of regulation of endothelial function at genetic (endothelial nitric oxide synthase polymorphisms) and post-transcriptional levels (circulating microRNAs) affect sCD40L serum levels. Lower quartiles of sCD40L (

AB - Involvement of soluble CD40 ligand (sCD40L) in thrombosis and inflammation on the context of coronary artery disease is currently being revised. In that perspective, we had studied the association of sCD40L with markers of platelet activation and markers of endothelial and vascular function. On that cohort, a stratification of patients with acute myocardial infarction (AMI) 1 month after percutaneous coronary intervention (PCI) was observed based on concentrations of sCD40L. The study intended to identify the groups of AMI patients with different profiles of sCD40L concentrations and verify how medication, clinical evolution, biochemical data, and markers of regulation of endothelial function at genetic (endothelial nitric oxide synthase polymorphisms) and post-transcriptional levels (circulating microRNAs) affect sCD40L serum levels. Lower quartiles of sCD40L (

UR - http://www.scopus.com/inward/record.url?scp=84973626872&partnerID=8YFLogxK

U2 - 10.1016/j.trsl.2016.04.005

DO - 10.1016/j.trsl.2016.04.005

M3 - Article

C2 - 27172386

AN - SCOPUS:84973626872

SP - 95

JO - Translational Research

JF - Translational Research

SN - 1931-5244

ER -